Inventor

MERCKEN MARC HUBERT

BE6 patents

⚠️ This page may combine multiple inventors who share the name “MERCKEN MARC HUBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCKEN MARC HUBERT

2 patents

US9329189B2May 3, 2016

N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions

MERCKEN MARC HUBERT6 citations74

US8911731B2Dec 16, 2014

Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof

MERCKEN MARC HUBERT1 citations37

JANSSEN PHARMACEUTICA NV

1 patent

US9939452B2Apr 10, 2018

N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses

JANSSEN PHARMACEUTICA NV2 citations66

GIJSEN HENRICUS JACOBUS MARIA

1 patent

US8461145B2Jun 11, 2013

Dibenzoazepine and dibenzooxazepine TRPA1 agonists

GIJSEN HENRICUS JACOBUS MARIA3 citations59

FREYNE EDDY JEAN EDGARD

1 patent

US7183288B2Feb 27, 2007

Amide derivatives as glycogen synthase kinase 3-β inhibitors

FREYNE EDDY JEAN EDGARD0 citations33

JANSSSEN PHARMACEUTICA N V

1 patent

US8383637B2Feb 26, 2013

2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)

JANSSSEN PHARMACEUTICA N V0 citations31